M4MM
New 2026 Farm Bill Draft Targets Industrial Hemp Burdens
WASHINGTON – House Agriculture Committee Chairman Glenn Thompson (R-PA) introduced a new Farm Bill draft (Farm, Food, and National Security Act of 2026), proposing changes that would ease certain federal requirements for industrial hemp growers. ...
Compass Pathways Advances in Second Phase 3 Trial for Psilocybin-Assisted TRD
LONDON – Compass Pathways PLC ADR, a UK-based mental health biotech company, announced that its second Phase 3 trial met the primary endpoint in evaluating COMP360, a synthetic formulation of psilocybin, for treatment-resistant depression (TRD). ...
350 Retail Cap and Tier V Cultivation Limits: What Virginia’s Scarcity Model Means for License Strategy
RICHMOND- Virginia’s adult-use design is built on scarcity and structural oversight. The 350 retail cap materially limits market density, shaping site selection and long-term valuation models. Tier V cultivation remains limited to five large operators. ...
Abandoned Fighter Jet Test Site Under Review for Cannabis Cultivation Facility
NEW YORK – A long-vacant former Grumman Aerospace complex in Calverton, NY, has become the subject of a preliminary proposal to repurpose its buildings for indoor Cannabis grow. The 20-acre property, which includes three office ...
Bioxyne Lands Initial Orders for GMP-Compliant Psilocybin Capsules
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, has received its first commercial orders for GMP-manufactured psilocybin capsules through its subsidiary Breathe Life Sciences (BLS). The capsules, branded BLSPSIL25, are intended ...
ANNOUNCING: ‘Future of Cannabis’ with Guy Rocourt Returns With Fresh Conversations on the Next Chapter of Cannabis
The fortnightly series brings a product-first, market-realistic lens to cannabis, covering regulation, capital, quality standards, and what real scale looks like as the industry matures. LOS ANGELES — February 12, 2026 — Highly Capitalized Network ...
Virginia Moves Closer to Cannabis Sales Launch
RICHMOND – Virginia's General Assembly moved forward with key Cannabis legislation, as committees approved measures to establish a regulated adult-use retail market and create a process for resentencing individuals convicted under older Cannabis laws. The ...
New 2026 Farm Bill Draft Targets Industrial Hemp Burdens
WASHINGTON – House Agriculture Committee Chairman Glenn Thompson (R-PA) introduced a new Farm Bill draft (Farm, Food, and National Security Act of 2026), proposing changes that would ease certain federal requirements for industrial hemp growers. ...
Compass Pathways Advances in Second Phase 3 Trial for Psilocybin-Assisted TRD
LONDON – Compass Pathways PLC ADR, a UK-based mental health biotech company, announced that its second Phase 3 trial met the primary endpoint in evaluating COMP360, a synthetic formulation of psilocybin, for treatment-resistant depression (TRD). ...
350 Retail Cap and Tier V Cultivation Limits: What Virginia’s Scarcity Model Means for License Strategy
RICHMOND- Virginia’s adult-use design is built on scarcity and structural oversight. The 350 retail cap materially limits market density, shaping site selection and long-term valuation models. Tier V cultivation remains limited to five large operators. ...
Kenyan MP Advocates for Regulated Cannabis Framework
NAIROBI – Peter Kalerwa Salasya, the outspoken member of Parliament for Kenya's Mumias East constituency, has ignited fresh debate on Сannabis policy by urging the government to pursue legalization under strict controls. Salasya highlighted the ...
OPINION: The Looming Federal Clampdown on THC Drinks and Hemp-Derived Edibles: What It Means for the Industry
NEW YORK- The quiet addition of a single paragraph in November’s federal shutdown bill has sent shockwaves through one of the fastest-growing segments of U.S. Cannabis: hemp-derived THC beverages and edibles. Unless Congress intervenes, a ...
Tilray Executes 1-for-10 Reverse Stock Split to Trim Shares and Cut Costs
NEW YORK – Tilray Brands Inc. confirmed it will carry out a 1-for-10 reverse stock split on its common shares, a step shareholders greenlit back in June to help the company meet Nasdaq listing standards ...
New York State OCM Updates Medical Cannabis Program, Expands Access for Out-of-State Patients
ALBANY – Governor Kathy Hochul signed a bill into law that extends New York's medical Cannabis program to patients certified in other states, marking the most substantial revision to the initiative since its 2016 launch. ...
New Brunswick Government Bets on Organigram with $2M Grant
MONCTON – Organigram Global Inc. has secured $2 million in provincial funding to support a $9.3 million project aimed at revamping its flagship cultivation site here. The upgrade, which targets lighting systems across 75 grow ...
Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone
DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...
Medicare Explores CBD Coverage for Seniors
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...
How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn
LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...
New Jersey Assembly Panel Clears Path for Psilocybin Therapy Program
TRENTON – New Jersey lawmakers advanced a bill that would allow supervised access to psilocybin for adults facing certain health challenges, establishing a regulated psilocybin therapy framework approved by the Assembly Health Committee. Assemblymember Anthony ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Operators and investors in Cannabis and Psychedelics faced a week of sharp contrasts. Federal action ended the longest government shutdown on record, yet it delivered a body blow to hemp-derived products that ...
Europe Advances Psychedelic Medicine with Targeted Approvals in Three Nations
BERLIN – Switzerland's long-standing framework for psychedelic treatments has set a course for its neighbors, as Germany and the Czech Republic roll out their own programs to address stubborn mental health conditions. These steps mark ...
Tilray Updated Investor Presentation Detailing Diversification Strategy
NEW YORK – Tilray Brands Inc. laid out its broadened ambitions in a new Investor Presentation. The document maps a course for the company to solidify its place as a consumer goods player, blending Cannabis ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay
TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays ...
